Previous 10 | Next 10 |
Axonics Modulation Technologies (NASDAQ: AXNX ) prices public offering of 4M common shares at $32.50, yielding gross proceeds of ~$130M. More news on: Axonics Modulation Technologies, Inc., , Tech stocks news, Read more ...
Image source: The Motley Fool. Axonics Modulation Technlogs INC (NASDAQ: AXNX) Q1 2020 Earnings Call May 05, 2020 , 4:30 p.m. ET Operator Continue reading
Gainers: MELI +18.9% . VAPO +15.9% . CLW +10.0% . NTNX +10.0% . AXNX +9.2% . More news on: MercadoLibre, Inc., Vapotherm, Inc., Clearwater Paper Corporation, Stocks on the move, , Read more ...
Axonics Modulation Technologies (NASDAQ: AXNX ): Q1 GAAP EPS of -$0.43 beats by $0.15 . More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today reported financial results for the firs...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H....
New Implantable Neurostimulator Decreases Recharge Interval to Only Once a Month Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that it will release financia...
Axonics Modulation Technologies (NASDAQ: AXNX ) submits a supplemental premarket approval (PMA) to the FDA to gain full-body magnetic resonance imaging (MRI) conditional labeling for 3.0T MRI scans. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Read mor...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced the submission of a premarket...
News, Short Squeeze, Breakout and More Instantly...
Axonics Modulation Technologies Inc. Company Name:
AXNX Stock Symbol:
NASDAQ Market:
Axonics Modulation Technologies Inc. Website:
AstraZeneca PLC (AZN) is expected to report $0.97 for Q2 2024 BJ's Restaurants Inc. (BJRI) is expected to report $0.49 for Q2 2024 Baker Hughes Company (BKR) is expected to report $0.49 for Q2 2024 BlueHarbor Bank (BLHK) is expected to report for Q2 2024 Betterware de Mexico S.A.P...
2024-06-19 23:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 07:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...